|
EIF4A3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.76429999999761E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.244640E-03 |
| Normal-vs-Stage2 |
5.179600E-04 |
| Normal-vs-Stage3 |
1.70759999995607E-06 |
| Normal-vs-Stage4 |
6.482100E-03 |
| Stage1-vs-Stage2 |
9.235800E-02 |
| Stage1-vs-Stage3 |
1.796290E-03 |
| Stage1-vs-Stage4 |
5.017800E-01 |
| Stage2-vs-Stage3 |
5.342200E-01 |
| Stage2-vs-Stage4 |
4.724400E-01 |
| Stage3-vs-Stage4 |
1.422630E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.29069999996479E-06 |
| Normal-vs-AfricanAmerican |
3.867500E-02 |
| Normal-vs-Asian |
3.224200E-01 |
| Caucasian-vs-AfricanAmerican |
2.790200E-01 |
| Caucasian-vs-Asian |
1.159030E-01 |
| AfricanAmerican-vs-Asian |
7.151600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.56371999999738E-05 |
| Normal-vs-Female |
2.356600E-03 |
| Male-vs-Female |
1.465430E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.935590E-02 |
| Normal-vs-Age(41-60Yrs) |
5.6752999999965E-05 |
| Normal-vs-Age(61-80Yrs) |
3.763800E-04 |
| Normal-vs-Age(81-100Yrs) |
2.227900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.189800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.380200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.142000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.821600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.051800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.473200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.900800E-01 |
| Normal-vs-Grade 2 |
2.703900E-03 |
| Normal-vs-Grade 3 |
1.04150000002079E-06 |
| Normal-vs-Grade 4 |
1.275130E-03 |
| Grade 1-vs-Grade 2 |
2.828600E-01 |
| Grade 1-vs-Grade 3 |
4.202000E-02 |
| Grade 1-vs-Grade 4 |
1.478170E-01 |
| Grade 2-vs-Grade 3 |
5.237800E-03 |
| Grade 2-vs-Grade 4 |
1.315040E-01 |
| Grade 3-vs-Grade 4 |
9.358600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.536900E-03 |
| Normal-vs-ccB subtype |
4.05820000000112E-05 |
| ccA subtype-vs-ccB subtype |
2.586100E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.59865999999065E-05 |
| Normal-vs-N1 |
2.565200E-01 |
| N0-vs-N1 |
3.147800E-01 |
|
|
